The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.

Umar Wazir(University of London), Kefah Mokbel(The Princess Grace Hospital), Anup Sharma(University of London), Wen G. Jiang(Shandong Center for Disease Control and Prevention), Robert F. Newbold(Brunel University of London)
PubMed
May 1, 2013
Cited by 26

Related Papers

SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome
|Nature Genetics|1998|628
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
|Nature|1983|444
The Multiple Sulfatase Deficiency Gene Encodes an Essential and Limiting Factor for the Activity of Sulfatases
|Cell|2003|367
Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cells
|Nature|1976|270
Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification
|Nature|1980|232